A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: FF/UMEC/VI;   Drug: Tiotropium;   Drug: Albuterol/salbutamol;   Drug: Placebo to match FF/UMEC/VI;   Drug: Placebo to match tiotropium;   Device: ELLIPTA inhaler;   Device: HANDIHALER;   Device: MDI Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2018 Category: Research Source Type: clinical trials

A Phase III Study to Evaluate the Efficacy and Safety of Anti-IgE Monoclonal Antibody in Allergic Asthma Patients.
Condition:   Asthma, Allergic Interventions:   Drug: CMAB007;   Drug: Symbicort;   Drug: Seretide;   Drug: Ventolin;   Drug: placebo Sponsor:   Shanghai Biomabs Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2018 Category: Research Source Type: clinical trials

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
Condition:   Asthma, Allergic Interventions:   Drug: CMAB007;   Drug: Symbicort;   Drug: Seretide;   Drug: Ventolin;   Drug: placebo Sponsor:   Shanghai Biomabs Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2018 Category: Research Source Type: clinical trials

Effects of Noninvasive Ventilation Compared to Salbutamol
Condition:   Asthma Interventions:   Device: Bilevel;   Drug: Albuterol Sponsor:   University of Nove de Julho Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2018 Category: Research Source Type: clinical trials

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
Condition:   Asthma Interventions:   Drug: FF/UMEC/VI;   Drug: FP/SAL;   Drug: Tiotropium;   Drug: Albuterol/salbutamol;   Device: ELLIPTA DPI;   Device: DISKUS DPI;   Device: RESPIMAT inhaler;   Device: Metered Dose Inhaler;   Device: Connected Inhaler System Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2017 Category: Research Source Type: clinical trials